Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy

Published:2016-07-06 Issue:1 Volume:14 Page:65-73
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Xiao Bo¹²,Ma Lijun¹,Merlin Didier²³

Affiliation:

1. Institute for Clean Energy and Advanced Materials, Faculty for Materials and Energy, Southwest University, Chongqing, P. R. China

2. Center for Diagnostics and Therapeutics, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA

3. Veterans Affairs Medical Center, Decatur, GA, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2016.1205583

Reference75 articles.

1. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

2. Chemotherapy and the war on cancer

3. Candidate mechanisms for chemotherapy-induced cognitive changes

4. The resurgence of platinum-based cancer chemotherapy

5. Excisional surgery for cancer cure: therapy at a cost

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced cytosolic RNA delivery through early endosome fusion-mediated release via probiotic-derived lipopolysaccharide (LPS)-incorporated vesicles;Nano Today;2024-12

2. Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy;Chinese Chemical Letters;2024-11

3. piR-823 tale as emerging cancer-hallmark molecular marker in different cancer types: a step-toward ncRNA-precision;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-05

4. Permanently Charged Cationic Lipids—Evolution from Excipients to Therapeutic Lipids;Small Science;2024-06-11

5. HER2 siRNA Facilitated Gene Silencing Coupled with Doxorubicin Delivery: A Dual Responsive Nanoplatform Abrogates Breast Cancer;ACS Applied Materials & Interfaces;2024-05-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3